Assessment of anti-arthritic activity of lipid matrix encased berberine in rheumatic animal model

References

• Alghadir, A., Miraj, M., and Ali, S., 2020. Efficacy of curcumin with iontophoretic application on paw edema and hematological responses in collagen-induced arthritis rat models. Evidence-based complementary and alternative medicine, 2020, 1–11.
   Web of Science ®Google Scholar
• Ansari, M.M., et al., 2021. Aminocellulose-grafted-polycaprolactone coated gelatin nanoparticles alleviate inflammation in rheumatoid arthritis: a combinational therapeutic approach. Carbohydrate polymers, 258, 117600.
   PubMed Web of Science ®Google Scholar
• Arora, R., et al., 2015. Curcumin loaded solid lipid nanoparticles ameliorate adjuvant‐induced arthritis in rats. European journal of pain, 19 (7), 940–952.
   PubMed Web of Science ®Google Scholar
• Augustine, M.S., et al., 2015. Cytotoxicity and cellular uptake of ZnS: Mn nanocrystals biofunctionalized with chitosan and aminoacids. Spectrochimica acta part A: molecular and biomolecular spectroscopy, 136, 327–333.
   PubMed Web of Science ®Google Scholar
• Bae, Y.-A. and Cheon, H.G. 2016. Activating transcription factor-3 induction is involved in the anti-inflammatory action of berberine in RAW264. 7 murine macrophages. The Korean journal of physiology & pharmacology, 20 (4), 415–424.
   PubMed Web of Science ®Google Scholar
• Beg, S., et al., 2018. QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques. Drug development and industrial pharmacy, 44 (3), 407–420.
   PubMed Web of Science ®Google Scholar
• Bullock, J., et al., 2018. Rheumatoid arthritis: a brief overview of the treatment. Medicine, principles and practice, 27 (6), 501–507.
   PubMed Web of Science ®Google Scholar
• Chuang, S.-Y., et al., 2018. Lipid-based nanoparticles as a potential delivery approach in the treatment of rheumatoid arthritis. Nanomaterial, 8 (1), 42.
   Web of Science ®Google Scholar
• Conforti, A., et al., 2021. Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmunity reviews, 20 (2), 102735.
   PubMed Web of Science ®Google Scholar
• Costa-Fernandez, S., et al., 2021. Nanostructured lipid carriers containing chitosan or sodium alginate for co-encapsulation of antioxidants and an antimicrobial agent for potential application in wound healing. International journal of biological macromolecules, 183, 668–680.
   PubMed Web of Science ®Google Scholar
• Deng, J., et al., 2020. Berberine-loaded nanostructured lipid carriers enhance the treatment of ulcerative colitis. International journal of nanomedicine, 15, 3937–3951.
   PubMed Web of Science ®Google Scholar
• Fang, C.-L., Al-Suwayeh, S.A., and Fang, J.-Y., 2013. Nanostructured lipid carriers (NLCs) for drug delivery and targeting. Recent patents on nanotechnology,7 (1), 41–55.
   PubMed Web of Science ®Google Scholar
• Gerber, D.A., 1975. Low free serum histidine concentration in rheumatoid arthritis. A measure of disease activity. The journal of clinical investigation,55 (6), 1164–1173.
   PubMed Web of Science ®Google Scholar
• Ghosh, S., et al., 2018. Methotrexate aspasomes against rheumatoid arthritis: optimized hydrogel loaded liposomal formulation with in vivo evaluation in Wistar rats. AAPS PharmSciTech, 19 (3), 1320–1336.
   PubMed Web of Science ®Google Scholar
• Guleria, A., et al., 2014. Metabolite characterisation in peritoneal dialysis effluent using high‐resolution 1H and 1H–13C. NMR spectroscopy, 52 (9), 475–479.
   Google Scholar
• Guo, Q., et al., 2018. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone research, 6 (1), 1–14.
   PubMed Web of Science ®Google Scholar
• Haugeberg, G., et al., 2002. Clinical decision rules in rheumatoid arthritis: do they identify patients at high risk for osteoporosis? Testing clinical criteria in a population based cohort of patients with rheumatoid arthritis recruited from the Oslo Rheumatoid Arthritis Register. Annals of the rheumatic diseases, 61 (12), 1085–1089.
   PubMed Web of Science ®Google Scholar
• Hu, Z., et al., 2011. Berberine induces dendritic cell apoptosis and has therapeutic potential for rheumatoid arthritis. Arthritis and rheumatism, 63 (4), 949–959.
   PubMed Web of Science ®Google Scholar
• Huang, D-n., et al., 2021. Efficacy of berberine in treatment of rheumatoid arthritis: from multiple targets to therapeutic potential. Pharmacological research 169, 105667.
   PubMed Web of Science ®Google Scholar
• Jadhav, D. and Vavia, P., 2021. Dexamethasone sodium phosphate loaded modified cyclodextrin based nanoparticles: an efficient treatment for rheumatoid arthritis. Journal of pharmaceutical sciences, 110 (3), 1206–1218.
   PubMed Web of Science ®Google Scholar
• Jia, M., et al., 2018. A novel dexamethasone-loaded liposome alleviates rheumatoid arthritis in rats. International journal of pharmaceutics, 540 (1-2), 57–64.
   PubMed Web of Science ®Google Scholar
• Kanoujia, J., et al., 2016. Novel genipin crosslinked atorvastatin loaded sericin nanoparticles for their enhanced antihyperlipidemic activity. Materials science & engineering, C, materials for biological applications, 69, 967–976.
   PubMed Web of Science ®Google Scholar
• Kapoor, B., et al., 2021. Fail-safe nano-formulation of prodrug of sulfapyridine: preparation and evaluation for treatment of rheumatoid arthritis. Materials science and engineering, C, 118, 111332.
   Google Scholar
• Karpuz, M. and Silindir-Gunay, M. 2022. Lipid‐based drug delivery systems and their role in infection and inflammation imaging. Nanoengineering of biomaterials, 1, 469–503.
   Google Scholar
• Kishore, N., et al., 2014. Solid lipid nano formulation for improved delivery of aceclofenac and its relevance in rheumatoid arthritis. Journal of nanopharmaceutics and drug delivery, 2 (3), 240–247.
   Google Scholar
• Krambeck, K., et al., 2021. Design and characterization of nanostructured lipid carriers (NLC) and nanostructured lipid carrier-based hydrogels containing Passiflora edulis seeds oil. International journal of pharmaceutics, 600, 120444.
   PubMed Web of Science ®Google Scholar
• Kumar, B., Das, M.P., and Misra, A.K., 2017. A cross-sectional study of association of rheumatoid arthritis with sero-positivity and anaemia in a tertiary care teaching hospital. Journal of medical research, 3, 280–283.
   Google Scholar
• Kusum, K., et al., 2022. Elevated circulatory proline to glutamine ratio (PQR) in endometriosis and its potential as a diagnostic biomarker. ACS omega, 7 (17), 14856–14866.
   PubMed Web of Science ®Google Scholar
• Lemon, H., Chasen, W., and Looney, J. M. 1952. Abnormal glycine metabolism in rheumatoid arthritis. The journal of clinical investigation, 31 (11), 993–999.
   PubMed Web of Science ®Google Scholar
• Liu, C.-S., et al., 2016. Research progress on berberine with a special focus on its oral bioavailability. Fitoterapia, 109, 274–282.
   PubMed Web of Science ®Google Scholar
• Liu, X., et al., 2016. Protective mechanisms of berberine against experimental autoimmune myocarditis in a rat model. Biomedicine & pharmacotherapy, 79, 222–230.
   PubMed Web of Science ®Google Scholar
• Mahdi, H.J., et al., 2018. In vivo anti-arthritic and anti-nociceptive effects of ethanol extract of Moringa oleifera leaves on complete Freund’s adjuvant (CFA)-induced arthritis in rats. Integrative medicine research, 7 (1), 85–94.
   PubMed Web of Science ®Google Scholar
• Nikam, A.P., Ratnaparkhiand, M.P., and Chaudhari, S.P., 2014. Nanoparticles–an overview. International journal of research and development in pharmacy & life sciences, 3, 1121–1127.
   Google Scholar
• Nisha, R., et al., 2020. Fabrication of imatinib mesylate-loaded lactoferrin-modified PEGylated liquid crystalline nanoparticles for mitochondrial-dependent apoptosis in hepatocellular carcinoma. Molecular pharmaceutics, 18 (3), 1102–1120.
   PubMed Web of Science ®Google Scholar
• Pal, R.R., et al., 2021. Synthesis of pH-sensitive crosslinked guar gum-g-poly (acrylic acid-co-acrylonitrile) for the delivery of thymoquinone against inflammation. International journal of biological macromolecules, 182, 1218–1228.
   PubMed Web of Science ®Google Scholar
• Pang, Z., et al., 2021. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic acids research, 49 (W1), W388–W396.
   PubMed Web of Science ®Google Scholar
• Parashar, P., et al., 2019. Dextrose modified bilosomes for peroral delivery: improved therapeutic potential and stability of silymarin in diethylnitrosamine-induced hepatic carcinoma in rats. Journal of liposome research, 29 (3), 251–263.
   PubMed Web of Science ®Google Scholar
• Prosperi, D., et al., 2017. Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases. Seminars in immunology, 34, 61–67.
   Google Scholar
• Pund, S., Borade, G., and Rasve, G., 2014. Improvement of anti-inflammatory and anti-angiogenic activity of berberine by novel rapid dissolving nanoemulsifying technique. Phytomedicine, 21 (3), 307–314.
   PubMed Web of Science ®Google Scholar
• Rajaram, C., Reddy, K.R., and Sekhar, K.B.C., 2015. Evaluation of anti-arthritic activity of Caesalpinia pulcherrima in Freund’s complete adjuvant induced arthritic rat model. Journal of young pharmacists, 7 (2), 128–132.
   Google Scholar
• Rawat, D., et al., 2015. Development and characterization of nanostructured lipid carriers of Vetiveria zizanoides oil for therapeutic potential in prickly heat treatment. Journal of pharmaceutical sciences and pharmacology, 2 (2), 162–171.
   Google Scholar
• Sabeti, B., et al., 2014. Characterization of diclofenac liposomes formulated with palm oil fractions. Tropical journal of pharmaceutical research, 13 (2), 185–190.
   Web of Science ®Google Scholar
• Sahin, K., et al., 2021. Niacinamide and undenatured type II collagen modulates the inflammatory response in rats with monoiodoacetate-induced osteoarthritis. Scientific reports, 11 (1), 1–15.
   PubMed Web of Science ®Google Scholar
• Scott, D., et al., 2000. The links between joint damage and disability in rheumatoid arthritis. Rheumatology, 39 (2), 122–132.
   PubMed Web of Science ®Google Scholar
• Sharma, M. and Chaudhary, D., 2021. Exploration of bromelain laden nanostructured lipid carriers: an oral platform for bromelain delivery in rheumatoid arthritis management. International journal of pharmaceutics, 594, 120176.
   PubMed Web of Science ®Google Scholar
• Shen, P., et al., 2020. Immunomodulatory effects of berberine on the inflamed joint reveal new therapeutic targets for rheumatoid arthritis management. Journal of cellular and molecular medicine, 24 (21), 12234–12245.
   PubMed Web of Science ®Google Scholar
• Singh, A., Bhat, T., and Sharma, O., 2011. Clinical biochemistry of hepatotoxicity. Journal of clinical toxicology S, 4, 2161–0495.
   Google Scholar
• Singh, M., et al., 2018. Augmented bioavailability of felodipine through an α-linolenic acid-based microemulsion. Drug delivery and translational research, 8 (1), 204–225.
   PubMed Web of Science ®Google Scholar
• Singh, N., et al., 2017. Oral delivery of allopurinol niosomes in treatment of gout in animal model. Journal of liposome research, 27 (2), 130–138.
   PubMed Web of Science ®Google Scholar
• Singh, P., et al., 2022. QbD-assisted development of lipidic nanocapsules for antiestrogenic activity of exemestane in breast cancer. Journal of liposome research, 32, 1–16.
   Google Scholar
• Sitton, N., et al., 1986. Serum and synovial fluid histidine: a comparison in rheumatoid arthritis and osteoarthritis. Rheumatology international, 6 (6), 251–254.
   PubMed Web of Science ®Google Scholar
• Sujitha, S., Dinesh, P., and Rasool, M. 2020. Berberine encapsulated PEG-coated liposomes attenuate Wnt1/β-catenin signaling in rheumatoid arthritis via miR-23a activation. European journal of pharmaceutics and biopharmaceutics : official journal of arbeitsgemeinschaft fur pharmazeutische verfahrenstechnik e.V, 149, 170–191.
   PubMed Web of Science ®Google Scholar
• Sultana, F. and Rasool, M., 2015. A novel therapeutic approach targeting rheumatoid arthritis by combined administration of morin, a dietary flavanol and non-steroidal anti-inflammatory drug indomethacin with reference to pro-inflammatory cytokines, inflammatory enzymes, RANKL and transcription factors. Chemico-biological interactions, 230, 58–70.
   PubMed Web of Science ®Google Scholar
• Trang, L.E., et al., 1985. Plasma amino acids in rheumatoid arthritis. Scandinavian journal of rheumatology, 14 (4), 393–402.
   PubMed Web of Science ®Google Scholar
• Tripathi, C.B., et al., 2018. QbD-based development of α-linolenic acid potentiated nanoemulsion for targeted delivery of doxorubicin in DMBA-induced mammary gland carcinoma: in vitro and in vivo evaluation. Drug delivery and translational research, 8 (5), 1313–1334.
   PubMed Web of Science ®Google Scholar
• Tripathi, C.B., et al., 2020. Biotin anchored nanostructured lipid carriers for targeted delivery of doxorubicin in management of mammary gland carcinoma through regulation of apoptotic modulator. Journal of liposome research, 30 (1), 21–36.
   PubMed Web of Science ®Google Scholar
• Uprit, S., et al., 2013. Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia. Saudi pharmaceutical journal, 21 (4), 379–385.
   PubMed Web of Science ®Google Scholar
• Wang, X., et al., 2017. Anti-arthritic effect of berberine on adjuvant-induced rheumatoid arthritis in rats. Biomedicine & pharmacotherapy, 89, 887–893.
   PubMed Web of Science ®Google Scholar
• Wen, S.-Q, et al., 2016. Discovery of novel berberine imidazoles as safe antimicrobial agents by down regulating ROS generation. Bioorganic & medicinal chemistry letters, 26 (12), 2768–2773.
   PubMed Web of Science ®Google Scholar
• Wong, S.K., Chin, K.-Y., and Ima-Nirwana, S., 2020. Berberine and musculoskeletal disorders: The therapeutic potential and underlying molecular mechanisms. Phytomedicine, 73, 152892.
   PubMed Web of Science ®Google Scholar
• Xue, M., et al., 2013. Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles. International journal of nanomedicine, 8, 4677.
   PubMed Web of Science ®Google Scholar
• Xue, M., et al., 2015. Berberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db mice. International journal of nanomedicine, 10, 5049.
   PubMed Web of Science ®Google Scholar
• Yu, F., et al., 2017. PEG–lipid–PLGA hybrid nanoparticles loaded with berberine–phospholipid complex to facilitate the oral delivery efficiency. Drug delivery, 24 (1), 825–833.
   PubMed Web of Science ®Google Scholar
• Zhang, F., et al., 2020. β-Sitosterol-loaded solid lipid nanoparticles ameliorate complete Freund’s adjuvant-induced arthritis in rats: involvement of NF-кB and HO-1/Nrf-2 pathway. Drug delivery, 27 (1), 1329–1341.
   PubMed Web of Science ®Google Scholar
• Zhang, L., et al., 2021. Micro-and nanoencapsulated hybrid delivery system (MNEHDS): a novel approach for colon-targeted oral delivery of berberine. Molecular pharmaceutics, 18 (4), 1573–1581.
   PubMed Web of Science ®Google Scholar
• Zheng, Z., et al., 2015. The effect of curcumin and its nanoformulation on adjuvant-induced arthritis in rats. Drug design, development and therapy, 9, 4931.
   PubMed Web of Science ®Google Scholar
• Zhou, L., et al., 2015. Berberine sulfate attenuates osteoclast differentiation through RANKL induced NF-κB and NFAT pathways. International journal of molecular sciences, 16 (11), 27087–27096.
   PubMed Web of Science ®Google Scholar
• Zhou, Y., et al., 2016. Berberine promotes proliferation of sodium nitroprusside-stimulated rat chondrocytes and osteoarthritic rat cartilage via Wnt/β-catenin pathway. European journal of pharmacology, 789, 109–118.
   PubMed Web of Science ®Google Scholar
• Zhuang, C.-Y., et al., 2010. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. International journal of pharmaceutics, 394 (1-2), 179–185.
   PubMed Web of Science ®Google Scholar